Global Minimal Residual Disease (MRD) Testing Market Size & Trends Report Segmented by Offering (Assay Kits/Reagents, Instruments, Services), Technology (PCR, NGS), Application (Haematological Malignancies, Solid Tumours), End-user (Hospitals, Specialty Clinics), & Regional Forecast to 2031

Global Minimal Residual Disease (MRD) Testing Market Segmentation

This report by Medi-Tech Insights provides the size of the global MRD testing market at the regional- and country-level from 2024 to 2031. The report further segments the market based on offering, technology, application, and end user. 

Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Offering, USD Billion

• Assay Kits & Reagents
• Instruments
• Services

Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Technology, USD Billion

• Polymerase Chain Reaction (PCR)
• Next-generation Sequencing (NGS)
• Flow Cytometry
• Other Technologies

Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Application, USD Billion

• Haematological Malignancies
• Leukaemia
• Lymphoma
• Solid Tumours
• Multiple Myeloma
• Other Applicatio

Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By End User, USD Billion

• Hospitals & Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa